Protein Drugs Analysis Report 2025-2029: Therapeutic Proteins Gain Traction for Targeted, Low-Toxicity Treatments, Competitive Landscape Intensifies as Leading Firms Expand Investments
The Protein Drugs Market, valued at USD 441.7 billion in 2024, is set to reach USD 655.7 billion by 2029, growing at an 8.2% CAGR. The report covers market trends, technologies, regional insights, and company profiles, highlighting the rise of recombinant protein drugs for treating diseases like cancer and diabetes.
Protein Drugs Market
Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Protein Drugs Market 2025" report has been added to ResearchAndMarkets.com's offering.The Protein Drugs Market was valued at USD 441.7 Billion in 2024, and is projected to reach USD 655.7 Billion by 2029, rising at a CAGR of 8.2%
The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.
Therapeutic proteins are a class of medicines that help treat a number of indications, such as cancer, diabetes, stroke, anemia and hemophilia. Protein drugs perform particular and complex functions compared to small molecules. Due to the high specificity, these protein drugs are less toxic and less likely to interfere with normal biological processes. Protein drugs can be manufactured in many ways, but most proteins are produced through recombinant deoxyribonucleic acid (rDNA) technology, using bacteria, yeast or mammalian cells as the host system.The report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent developments.The report includes:
79 data tables and 57 additional tables
An analysis of the global markets for protein drugs and their manufacturing technologies
Analyses of the global market trends, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the size of and revenue prospects for the global market, along with a market share analysis by type of protein drug, manufacturing technology, and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Analysis of the advances in manufacturing technologies, disease prevalence trends, new products, and the impact of biosimilars entering the market for protein drugs
An analysis of patents and significant patent grants
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies, including: AbbVie Inc., Bristol Myer Squibb, Merck & Co., Novo Nordisk S/A, Sanofi, and Roche
Key Attributes:
Report Attribute
Details
No. of Pages
162
Forecast Period
2024 - 2029
Estimated Market Value (USD) in 2024
$441.7 Billion
Forecasted Market Value (USD) by 2029
$655.7 Billion
Compound Annual Growth Rate
8.2%
Regions Covered
Global
Key Topics Covered: Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Current and Future Market Overview
Technology Background
Pharmacological Classification of Therapeutic Proteins
Protein Therapeutics with Enzymatic or Regulatory Activity
Protein Therapeutics with Special Targeting Activity
Protein Vaccines
Characteristics of Therapeutic Proteins
Macroeconomic Factors
Porter's Five Forces Analysis
Supply Chain Analysis
R&D
Manufacturing
Packaging
Wholesale Distributors and Repackagers
Pharmacies/Hospitals
Dispensed to Consumers
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Advances in Manufacturing Technologies
Continuous Product Launches
Increasing Incidence of Cancer
Market Restraints
High Costs of Protein Drugs
Complex Regulatory Procedures
Market Challenges
Patent Expiration and Loss of Exclusivity
Protein Drugs Stability and Delivery
Market Opportunities
Increasing Number of Approvals for MAbs
Licensing and Collaboration Agreements
Chapter 4 Regulatory Landscape
Regulatory Scenario
Price Regulations
Chapter 5 Emerging Technologies
Overview
Emerging Technologies in Protein Drugs Market
Bispecific Antibodies and Multi-Specific Antibodies
Antibody-Drug Conjugates
Antibody Fusion Proteins
AI in the Protein Drug Market
Chapter 6 Market Segment Analysis
Overview
Segmentation Breakdown
Global Market for Protein Drugs, by Type
MAbs
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
Fusion Proteins
Global Market for Protein Drugs, by Manufacturing Technology
Cell Culture
Microbial Fermentation
Natural Source
Embryonated Egg
Chemical Synthesis
Transgenics
Market Breakdown by Region
Global Market for Protein Drugs, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Industry Structure
Leading Protein Drugs, 2023
Market Share Analysis
MAbs
Peptide Hormones
Strategic Analysis
Acquisitions
Product Approvals
Agreements and Partnerships
Other Strategies
Chapter 8 Sustainability in the Protein Drug Market: ESG Perspective
Sustainability in the Protein Drug Industry
ESG Risk Ratings: Understanding the Data
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks
Companies Featured
AbbVie Inc.
Amgen Inc.
Astrazeneca
Bayer AG
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Lilly
Merck & Co. Inc.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Takeda Pharmaceutical Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/k72fez
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Protein Drugs Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
4 hours ago
- Business Upturn
GradGuard Honors National Insurance Awareness Day by Awarding $15,000 in Scholarships to College Students
By GlobeNewswire Published on June 28, 2025, 19:30 IST PHOENIX, June 28, 2025 (GLOBE NEWSWIRE) — GradGuard, the authority in helping protect students and their families from the risks of college life through its pioneering tuition and renters insurance programs, is pleased to announce the winners of its inaugural scholarship program, awarding $3,000 each to five outstanding students across the country. As part of its mission to help schools educate and protect students from the risks of college life, GradGuard launched the no-essay scholarship program to highlight the importance of being prepared for the unexpected. With nearly 600 applicants nationwide, the five winners were selected for their content, creativity, and presentation style in sharing personal college experiences, stories, or real-world scenarios that demonstrate the value of tuition or renters protection to enable students to overcome common disruptions to college life. 'Hearing the authentic voices of students helps to demonstrate that the risks are real,' said John Fees, GradGuard's co-founder. 'With nearly 2,000 annual campus fires and more than 22,000 crimes reported annually the value of renters insurance to protect students from theft or damages is a vital consideration, while tuition insurance can helps to safeguard their financial investment if they need to withdraw for a covered reason such as an accident, injury or physcal or mental health condition.' 2025 Scholarship Winners: Emily Goldner-Morgan, Boise State University Jazmin Goodwin, Arizona State University Kara Haj, University of California, Los Angeles Wes Orr, Abilene Christian University Michael Seepersaud, Georgian Court University Each student will receive $3,000 to help offset tuition, books, housing, or other college-related expenses. National Insurance Awareness Day, observed annually on June 28, serves as a vital reminder for the nearly 20 million college students to assess their insurance needs and ensure adequate protection against the unique risks of college life. GradGuard's scholarship program and its work with more than 650 colleges and universities help to promote greater financial literacy and enable students to make smart decisions to protect themselves from financial risks that can otherwise disrupt their education. 'We believe in investing directly in students, and our scholarship program is a testament to that commitment,' adds Fees. 'Congratulations to Emily, Jazmin, Kara, Wes, and Michael. We are incredibly proud to support their academic pursuits and wish them all the best.' For more information about GradGuard's college renters and tuition insurance programs, and to learn about future scholarship opportunities, please visit About GradGuard: GradGuard is the authority on helping schools educate and protect students from the risks of college life. As the #1 source of college tuition and renters insurance, GradGuard's pioneering protections have served more than 1.8 million students at more than 1,900 unique institutions. To learn more, visit Attachment GradGuard's 2025 Scholarship Recipients Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
4 hours ago
- Business Upturn
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Apple Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the 'Class Period'). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 19, 2025. SO WHAT: If you purchased Apple securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Apple class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 19, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Apple misstated the time it would take to integrate the advanced AI-based Siri features into its devices; (2) accordingly, it was highly unlikely that these features would be available for the iPhone 16; (3) the lack of such advanced AI-based features would hurt iPhone 16 sales; (4) as a result, Apple's business and/or financial prospects were overstated; and (5) as a result, Apple's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Apple class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
Business Upturn
4 hours ago
- Business Upturn
Autonomous Driving Software Market to Reach USD 5.6 Billion by 2032, Driven by Connected Mobility and Safety Demands
Pune, June 28, 2025 (GLOBE NEWSWIRE) — Autonomous Driving Software Market Size Analysis: 'The SNS Insider report indicates Autonomous Driving Software Market size was valued at USD 1.8 billion in 2023 and is estimated to reach USD 5.58 billion by 2032, growing at a compound annual growth rate (CAGR) of 13.58% during the forecast period 2024–2032.' In 2023, the U.S. market was valued at approximately USD 0.5 billion and is projected to reach USD 1.55 billion by 2032, growing at a CAGR of around 13.47% from 2024 to 2032. Growth is driven by strong R&D investments, regulatory support for AV testing, and rapid advancements in AI and sensor technologies. Get a Sample Report of Autonomous Driving Software Market@ Major Players Analysis Listed in this Report are: Aptiv (Aptiv Autonomous Driving Platform, Smart Vehicle Architecture) Aurora Innovation Inc. (Aurora Driver, Aurora Horizon) Baidu, Inc. (Apollo Autonomous Driving Platform, Apollo Go Robotaxi) Continental AG (ContiConnect, Continental Autonomous Driving System) Huawei Technologies Co., Ltd. (Huawei Autonomous Driving Platform, HiCar) Mobileye (EyeQ5, Mobileye Roadbook) Nvidia Corporation (NVIDIA Drive Platform, NVIDIA DRIVE Sim) (PonyPilot, PonyOS) Qualcomm Technologies, Inc. (Qualcomm Autonomous Driving Platform, Snapdragon Ride) Robert Bosch GmbH (Bosch Autonomous Driving Solutions, Bosch ADAS Radar) Waymo (Waymo Driver, Waymo One) Uber ATG (Uber Advanced Technologies Group, Uber ATG Self-Driving System) Tesla, Inc. (Full Self-Driving (FSD), Autopilot) Apple Inc. (Apple Car Project, Apple Autonomous Driving Platform) Zoox (Zoox Autonomous Vehicle, Zoox Self-Driving System) Velodyne Lidar (Velodyne Alpha Puck, Velodyne VLS-128 Lidar) Autoliv (Autoliv Autonomous Driving Safety, Autoliv Vision System) LeddarTech (LeddarPixell, LeddarVision) Daimler AG (Mercedes-Benz Autonomous Driving System, Drive Pilot) Autonomous Driving Software Market Report Scope: Report Attributes Details Market Size in 2023 US$ 1.78 Billion Market Size by 2032 US$ 5.58 Billion CAGR CAGR of 13.58% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Key Segments • By Level of Autonomy (L1, L2, L3, L4 & L5) • By Propulsion (ICE, Electric Vehicles) • By Vehicle Type (Passenger Vehicles, Commercial Vehicles) • By Software Type (Perception & Planning Software, Chauffeur Software, Interior Sensing Software, Supervision/Monitoring Software) Key Growth Drivers Rising Consumer Demand for Safer and More Efficient Transportation Drives Autonomous Vehicle Software Growth Do you have any specific queries or need any customization research on Autonomous Driving Software Market, Make an Enquiry Now@ By Level of Autonomy: L2 Leads, L4 & L5 to Surge with Advanced AI Integration The L2 segment dominated the market in 2023 and accounted for 42% of revenue share, owing to the maturity of L2 automation and its widespread adoption in modern vehicles. L2 is the semi-autonomous driving class and the de facto mainstream spec provided across the OEM landscape, with functionalities like adaptive cruise control and lane-keeping assistance. The L4 & L5 segment is anticipated to grow at the fastest pace, with companies such as Waymo, Cruise, and Baidu already testing fully autonomous prototypes within just a few years of rapid AI development. These levels allow for complete vehicle autonomy, with L5 having no human intervention at all. When regulations are adapted to changing landscapes and infrastructure is upgraded to meet the needs of full autonomy, L4 and L5 will experience exponential growth. By Propulsion: ICE Vehicles Dominate While EV Segment Accelerates Fastest Growth Internal combustion engine (ICE) vehicles dominated the market in 2023 and accounted for 64% of revenue share, due in part to its high US installed base and ongoing improvements in semi-autonomous functionality. As OEMs take their first steps toward electrification, they need to maintain a fingerhold in the old ICE world relative to the competition and must therefore integrate the autonomous functionality into these legacy platforms. Moreover, the ICE vehicle infrastructure is still strong all over the world, but especially in developing economies where people are expected to resist the switch to EVs, which means there's still demand. Electric vehicles (EVs) are expected to witness the fastest CAGR during the forecast period, attributed to their compatibility with autonomous driving systems. EV architectures provide for easier integration of SD features and driving algorithms with the help of greater efficiency and energy consumption. EV platforms have also been turned into testbeds for autonomous automakers. With new breakthroughs in battery range technology and a growing smart charging infrastructure, the convergence of EV and Autonomous technology will usher in the next frontier of mobility. By Vehicle Type: Passenger Vehicles Lead While Commercial Vehicles Set to Grow Rapidly Passenger vehicles dominated the market in 2023 and accounted for 72% of revenue share due to increasing consumer adoption of driver-assistance systems and safety. With the market for new buyer-acquisition sources getting tighter, automakers are pouring serious dollars into dozens of advanced autonomous software making it into sedans and SUVs with the goal of keeping the customer happy while not splitting their head open on the dashboard, and to differentiate in a split automotive market. The trend regarding software-defined vehicles is primarily driven by consumers Commercial vehicles, however, are projected to grow at the fastest rate due to increasing demand for automated logistics, last-mile delivery, and long-haul freight efficiency. Commercial vehicles will witness the fastest growth. The advantages of autonomous driving trucks, vans, and delivery robots will be the reduction of labor costs, the optimized fleet utilization, and the benefit of speed throughput. Driven by the need for operational scalability, the commercial vehicle segment will witness strong software consolidation. By Software Type: Perception & Planning Leads, Interior Sensing Grows Fastest with Cabin Intelligence Perception & planning software dominated the market in 2023 and accounted for 43% of revenue share, as it serves as the bedrock of autonomous driving systems by providing real-time environmental awareness and trajectory planning capabilities. Such modules fuse input from LiDAR, radar, and cameras they enabling real-time decisions and are therefore critical to anything above the lowest levels of vehicle autonomy. Interior sensing software is expected to grow at the fastest CAGR because of increasing regulatory requirements for driver monitoring, drowsiness detection, and in-cabin safety features. With the transformation of the vehicle cabin into an intelligent, responsive environment, vehicle personalisation and passenger privacy will drive software add-on demand, claimed the report. Buy an Enterprise-User PDF of Autonomous Driving Software Market Analysis & Outlook 2024-2032@ By Region: North America Leads, Asia-Pacific Emerges as Fastest Growing Market North America dominated the autonomous driving software market in 2023 and accounted for 39% of revenue share, due to increased output on the part of automotive OEMs, R&D investments, and regulatory frameworks. With many pilot programs, AV tests infrastructure, and of course, AI innovation centers going on, the U.S., in particular, takes the lead. Asia-Pacific is projected to grow at the highest CAGR during 2024–2032, driven primarily by China, Japan and South Korea. Rising Urbanization, Investments in Smart Mobility, and Government-backed Autonomous Initiatives are Accelerating Regional Adoption. About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
